89. Lymphangioleiomyomatosis Clinical trials / Disease details

Clinical trials : 38 /  Drugs : 38 - (DrugBank : 15) / Drug target genes : 18 - Drug target pathways : 118

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04388371
(ClinicalTrials.gov)		October 18, 201911/5/2020Glutamine PET Imaging in LAMGlutamine PET Imaging in LAMLymphangioleiomyomatosis (LAM)Drug: GlutamineVanderbilt University Medical CenterThe LAM FoundationCompleted18 YearsN/AFemale5Phase 1United States